FTC Approves Horseracing Integrity and Safety Authority’s Anti-Doping and Medication Control Rule

The Federal Trade Commission has issued an Order approving the Anti-Doping and Medication Control rule proposed by the Horseracing Integrity and Safety Authority after a public comment period. The rule will take effect today.


The Horseracing Integrity and Safety Act, which recognized the Authority, includes a requirement that its rules (and any future modifications to those rules) must be submitted for approval to the FTC. The Act requires that the FTC approve submitted rules if it finds that they are “consistent with” the Act and the FTC’s procedural rules governing the submission process.


The FTC’s procedural rule provides that the FTC will publish the Authority’s proposed rules in the Federal Register for public comment if the Authority’s submissions meet certain criteria. Under the Act, the FTC had 60 days from the date of publication to approve or disapprove the proposed rule.


The Commission vote to approve the rule was 3-0-1, with Commissioner Christine S. Wilson abstaining.

The Federal Trade Commission works to promote competition and protect and educate consumers. Learn more about consumer topics at consumer.ftc.gov, or report fraud, scams, and bad business practices at ReportFraud.ftc.gov. Follow the FTC on social media, read consumer alerts and the business blog, and sign up to get the latest FTC news and alerts.